lisuride has been researched along with thiazoles in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, F; Giuliani, D | 3 |
| Gerlach, J; Peacock, L | 1 |
| Montastruc, JL; Rascol, O; Senard, JM | 1 |
| Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A | 1 |
| Gekht, AB | 1 |
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
3 review(s) available for lisuride and thiazoles
| Article | Year |
|---|---|
Treatment of Parkinson's disease should begin with a dopamine agonist.
Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles | 1999 |
[Use of dopamine agonists in the treatment of Parkinson's disease].
Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors | 2002 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
5 other study(ies) available for lisuride and thiazoles
| Article | Year |
|---|---|
Effect on rat feeding behavior of two selective D2 dopamine agonists.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Benzothiazoles; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Feeding Behavior; Lisuride; Male; Maze Learning; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Social Environment; Stereotyped Behavior; Thiazoles | 1994 |
Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Azepines; Behavior, Animal; Benzothiazoles; Dioxanes; Dopamine Agents; Dose-Response Relationship, Drug; Idazoxan; Lisuride; Male; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior; Thiazoles | 1993 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |
Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats.
Topics: Animals; Benzothiazoles; Cocaine; Copulation; Dopamine Agonists; Dopamine Antagonists; Lisuride; Male; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides; Sexual Behavior, Animal; Specific Pathogen-Free Organisms; Thiazoles | 1997 |
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome | 2001 |